CenterBook Partners LP Makes New $1.23 Million Investment in Sotera Health Company $SHC

CenterBook Partners LP acquired a new position in shares of Sotera Health Company (NASDAQ:SHC) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 78,056 shares of the company’s stock, valued at approximately $1,228,000.

Other large investors have also recently bought and sold shares of the company. Empowered Funds LLC boosted its stake in Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after buying an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after acquiring an additional 43,471 shares during the last quarter. Acadian Asset Management LLC boosted its stake in shares of Sotera Health by 125.5% in the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after purchasing an additional 14,018 shares in the last quarter. Vanguard Personalized Indexing Management LLC grew its holdings in shares of Sotera Health by 38.3% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 17,878 shares of the company’s stock valued at $199,000 after purchasing an additional 4,951 shares during the last quarter. Finally, First Citizens Bank & Trust Co. grew its holdings in shares of Sotera Health by 265.8% during the 2nd quarter. First Citizens Bank & Trust Co. now owns 61,610 shares of the company’s stock valued at $685,000 after purchasing an additional 44,767 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SHC has been the topic of several recent research reports. Wells Fargo & Company downgraded shares of Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Sotera Health in a report on Monday, December 29th. Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, January 30th. BMO Capital Markets assumed coverage on Sotera Health in a research report on Thursday, November 13th. They set an “outperform” rating and a $19.00 target price for the company. Finally, JPMorgan Chase & Co. lifted their target price on Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a report on Wednesday, November 5th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $20.00.

Insider Activity at Sotera Health

In related news, CEO Michael B. Jr. Petras sold 434,104 shares of the business’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $16.45, for a total value of $7,141,010.80. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the business’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the completion of the transaction, the director owned 22,735,301 shares in the company, valued at approximately $371,267,465.33. The trade was a 22.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 17,384,104 shares of company stock valued at $284,024,511 over the last ninety days. Corporate insiders own 47.55% of the company’s stock.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $17.49 on Friday. Sotera Health Company has a twelve month low of $9.53 and a twelve month high of $19.85. The stock’s 50 day moving average is $17.97 and its 200-day moving average is $16.69. The company has a quick ratio of 2.18, a current ratio of 2.38 and a debt-to-equity ratio of 4.04. The firm has a market capitalization of $4.97 billion, a price-to-earnings ratio of 92.06 and a beta of 1.82.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.